ASCIA Newsletter January 2017

This email contains pictures, if you don’t see them, view it online
 
ASCIA Update aims to provide current information to the community about allergic diseases, immunodeficiencies and other immune diseases.
 
  ASCIA UPDATE - January 2017  
 
 
 

ASCIA Update aims to provide current information to the community about allergic diseases, primary immunodeficiencies and other immune diseases.

 
 
--
 

Back to school with allergies 

schools in 2017As children all around Australia and New Zealand start a new school year it is time to ensure ASCIA Action Plans are up to date. These should be reviewed and reissued when children with diagnosed allergies are reassessed by their doctor, and each time they obtain a new adrenaline autoinjector prescription, which is approximately every 12 to 18 months.

ASCIA has free downloadable information for schools, students and parents that you can access here.

ASCIA anaphylaxis e-training courses for schools and childcare are world leading courses that provide access to accurate, up to date and consistent anaphylaxis education throughout Australia and New Zealand, at no charge www.allergy.org.au/patients/anaphylaxis-e-training-schools-and-childcare

Allergy & Anaphylaxis Australia and Western Sydney University have co-produced a new video to help parents of children with food allergies confidently make the transition from preschool and childcare to primary school. Watch the video here.

This is also a good time to think of joining the Allergy and Immunology Foundation of Australasia (AIFA) and the allergy community fundraise in schools for research to help find out why allergy is increasing and what can be done about it. AIFA has a new fundraising toolkit that is full of great ideas to make it easier to get involved in supporting research. Access the toolkit and a calendar of already scheduled events here

 
 

ASCIA projects 2017    

As outlined in the highlights summary for 2016 www.allergy.org.au/about-ascia/highlights  several ASCIA projects are planned for 2017, including:

  • New ASCIA food allergen challenge register (currently being piloted)
  • New ASCIA immunodeficiency register (in final stages of development)
  • Completion of current government funded National Allergy Strategy projects and commencement of new projects (see update below) Increased AIFA research fundraising and collaborations
  • New ASCIA allergic rhinitis e-training and resources for pharmacists (in final stages of development) New ASCIA drug allergy e-training and resources (in final stages of development)
  • Updated and new ASCIA guidelines, clinical updates and position papers
  • TAPID face to face meeting – 20-21 May 2017
  • ASCIA advanced training meeting (environmental allergy) - 29 July 2017

For further information go to www.allergy.org.au/about-ascia/ascia-initiatives

 
 

National Allergy Strategy update 

The past few months have been a busy time for the National Allergy Strategy, with all of the following government funded projects progressing well:

Drug allergy project: Further to meetings with the Australian Digital Health Agency (ADHA) and the Australian Commission for Safety and Quality in Health Care (ACSQHC), the ADHA has agreed to prioritise working with the National Allergy Strategy on the allergy component of My Health Record.

Teens and young adults project: Data analysed from a national survey of young people at risk of anaphylaxis is being used to inform resource development and work has already commenced on this, through engagement with professional agencies.

Food service project: At the National Allergy Strategy Food Service Forum for Food Allergy in October 2016, representatives from key stakeholder organisations agreed that an online training course should be developed for food service staff. Work is underway on this as well as consumer resources for food allergic individuals and carers.

New project: Shared care model for allergy Seed funding to support the National Allergy Strategy shared care model initiative has been secured, so this project will progress in 2017-2018.

For further information about the National Allergy Strategy go to www.nationalallergystrategy.org.au 

 
 

CVID Story Builds Awareness 

emily 2017Emily Dixon recently shared her story about living with CVID with the AIFA community. Most people with Common Variable Immune Deficiency (CVID) are not diagnosed until 30 to 40 years of age even though 1 in 5 of them experienced the symptoms in childhood.

The symptoms are recurrent infections due to reduced immune responses usually in the ears, sinuses, nose and lungs and can include conjunctivitis and persistent diarrhoea. Although these infections can affect anyone, if you have CVID they are unusually recurrent, prolonged, severe or resistant to normal treatment.

The causes of CVID are not yet known. More research and awareness is urgently needed. Contribute to an AIFA research grant here.

There are many children with immune deficiencies making their way back to school. It is because of them that AIFA strives to fund research that will lead to earlier diagnosis, strategies for prevention, better treatments and potential cures.

If you missed it, you can still read Emily's story at www.allergyimmunology.org.au/personal-stories/cvid-emily-s-story 

 
---
 
 
ASCIAThe mission of ASCIA is to advance the science and practice of allergy and clinical immunology, by promoting the highest standard of medical practice, training, education and research, to improve the health and quality of life of people with allergic diseases, immunodeficiencies and other immune diseases.
 
 
 
AIFAAIFA is dedicated to improving the health of people with allergy and other immune diseases by funding medical research and raising awareness. 
Donate here…
 
     
 
 
twitterfacebookwww.allergy.org.au | contact us
Prefer not to receive our news anymore